TLC-6740

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameTLC-6740
Drug Alias NameTLC-6740
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitochondrial oxidative phosphorylation inhibitors
TargetsNot applicable
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2Diabetes Mellitus +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew Zealand
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGilead Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesOrsoBio Inc
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2Diabetes Mellitus +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A